INS and obesity due to melanocortin 4 receptor deficiency: SCFAs also increase insulin levels (via GSIS) independent of blood glucose concentrations, and increase muscular and systemic insulin sensitivity, and obesity-related reductions in SCFAs promote peripheral insulin resistance and consequently hyperinsulinemia [101].